Search

everythinglearnresearchcommunity

for

Search:↓

The symposium highlighted the importance of genetics in understanding and treating complex skin diseases.

Transplant success has improved with better immunosuppressive drugs and donor matching.

A genetic marker linked to a type of hair loss was found in most patients studied.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Keratinocytes and adipose-derived stem cells can effectively heal difficult skin wounds.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Wharton’s Jelly stem cells from the umbilical cord improve skin healing and hair growth without scarring.

TGM3 is important for skin and hair structure and may help diagnose cancer.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Both HLA-B and MICA are independently linked to alopecia areata.

Most women with ankylosing spondylitis tested positive for HLA-B27, suggesting it's useful for diagnosis.

Corticosteroid therapy reduces specific immune cells and promotes hair growth in alopecia areata patients.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Mercury allergy linked to specific genes may contribute to burning mouth syndrome, and silicon might play a role in maintaining healthy hair.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.